Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk J Blom

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Cardiovascular Journal of Africa|October 4, 2022
A report card for healthy aging in South AfricaDirk J Blom
Global Journal on Quality and Safety in Healthcare|August 6, 2024
Letter in Response to "Lomitapide: A Medication Use Evaluation and a Formulary Perspective" by Esba and AlharbiDirk J Blom
Journal of the American College of Cardiology|April 1, 2025
Beyond LDL: Targeting ANGPTL3 to Reduce Residual Cardiovascular RiskDirk J Blom, Daniel Gaudet
The American Journal of Medicine|April 6, 2005
Severe hypertriglyceridemia in a patient with lupusDirk J Blom, A David Marais
Current Opinion in Lipidology|July 11, 2013
Recent advances in the treatment of homozygous familial hypercholesterolaemiaAdrian D Marais, Dirk J Blom
Lancet (London, England)|March 7, 2015
Anacetrapib in familial hypercholesterolaemia: pros and consFrederick J Raal, Dirk J Blom
Atherosclerosis. Supplements|September 27, 2014
Clinical experience of lomitapide therapy in patients with homozygous familial hypercholesterolaemiaMarina Cuchel, Dirk J Blom, Maurizio R Averna
Orphanet Journal of Rare Diseases|June 22, 2018
Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial HypercholesterolaemiaDirk J Blom, Marina Cuchel, Miranda Ager, et al.
Current Atherosclerosis Reports|January 3, 2025
Homozygous Familial Hypercholesterolemia Treatment: New DevelopmentsDirk J Blom, A David Marais, Frederick J Raal
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 22, 2008
Discovering familial hypercholesterolaemiaDirk J Blom, Frederick J Raal, A David Marais
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Cardiovascular Journal of Africa|October 4, 2022
A report card for healthy aging in South AfricaDirk J Blom
Global Journal on Quality and Safety in Healthcare|August 6, 2024
Letter in Response to "Lomitapide: A Medication Use Evaluation and a Formulary Perspective" by Esba and AlharbiDirk J Blom
Journal of the American College of Cardiology|April 1, 2025
Beyond LDL: Targeting ANGPTL3 to Reduce Residual Cardiovascular RiskDirk J Blom, Daniel Gaudet
The American Journal of Medicine|April 6, 2005
Severe hypertriglyceridemia in a patient with lupusDirk J Blom, A David Marais
Current Opinion in Lipidology|July 11, 2013
Recent advances in the treatment of homozygous familial hypercholesterolaemiaAdrian D Marais, Dirk J Blom
Lancet (London, England)|March 7, 2015
Anacetrapib in familial hypercholesterolaemia: pros and consFrederick J Raal, Dirk J Blom
Atherosclerosis. Supplements|September 27, 2014
Clinical experience of lomitapide therapy in patients with homozygous familial hypercholesterolaemiaMarina Cuchel, Dirk J Blom, Maurizio R Averna
Orphanet Journal of Rare Diseases|June 22, 2018
Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial HypercholesterolaemiaDirk J Blom, Marina Cuchel, Miranda Ager, et al.
Current Atherosclerosis Reports|January 3, 2025
Homozygous Familial Hypercholesterolemia Treatment: New DevelopmentsDirk J Blom, A David Marais, Frederick J Raal
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 22, 2008
Discovering familial hypercholesterolaemiaDirk J Blom, Frederick J Raal, A David Marais
Pageof 8